Rh phenotypes of iPSCs used to generate iRBCs
Lines . | PSC . | ABO . | RHD∗ RHCE∗ genotypes and presumed haplotypes . | Rh antigen phenotype . | Application as reagent RBC in antibody identification . | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
D . | C . | c . | E . | e . | hrS . | hrB . | V . | VS . | |||||
DCe (R1R1) | ESC | O | ∗D ∗Ce homozygous | + | + | 0 | 0 | + | + | + | 0 | 0 | Routinely used Rh phenotype lacking c and E |
DcE (R2R2) | iPSC | O | ∗D ∗cE No RHD ∗cE | + | 0 | + | + | 0 | 0 | + | 0 | 0 | Routinely used Rh phenotype lacking C and e |
ce (rr) | iPSC | O | No RHD ∗ce homozygous | 0 | 0 | + | 0 | + | + | + | 0 | 0 | Routinely used Rh phenotype lacking D, C, and E |
hrS− | iPSC∗ | O | ∗DAU0 ∗ceMO ∗DOL ∗ceBI | + | 0 | + | 0 | + | 0 | + | 0 | 0 | Uncommon; lacks high-prevalence antigen hrS Anti-hrS would be (0) nonreactive |
hrB− | iPSC∗ | O | ∗DIIIa-CE(4-7)-D ∗ceS homozygous | + | + | + | 0 | + | + | 0 | 0 | 0 | Uncommon; lacks high-prevalence antigen hrB Anti-hrB would be (0) nonreactive |
V+VS+ | iPSC∗ | O | ∗D ∗ce733G ∗DFV ∗ce733G | + | 0 | + | 0 | + | + | + | + | + | Uncommon; expresses low-prevalence antigens V and VS Anti-V/VS would be (+) reactive |
Rh null | iPSC | O | No RHD ∗ce (1kb del. KO) homozygous | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | Exceedingly rare; lacks RhD and RhCE proteins (0) nonreactive suggests antibody in the Rh system |
D-- | iPSC | O | RHD cDNA inserted at AAVS1 locus of Rh null iPSC | + | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | Exceedingly rare; expresses RhD and no RhCE (0) nonreactive suggests antibody to RhCE antigens |
Goa+ | iPSC | O | RHD∗DIVa cDNA inserted at AAVS1 locus of Rh null iPSC | + | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | Expresses low-prevalence antigen Goa, RhD, and no RhCE Anti-Goa would be (+) reactive |
DAK+ | iPSC | O | RHD∗DIIIa cDNA inserted at AAVS1 locus of Rh null iPSC | + | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | Expresses low-prevalence antigen DAK, RhD, and no RhCE Anti-DAK would be (+) reactive |
Lines . | PSC . | ABO . | RHD∗ RHCE∗ genotypes and presumed haplotypes . | Rh antigen phenotype . | Application as reagent RBC in antibody identification . | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
D . | C . | c . | E . | e . | hrS . | hrB . | V . | VS . | |||||
DCe (R1R1) | ESC | O | ∗D ∗Ce homozygous | + | + | 0 | 0 | + | + | + | 0 | 0 | Routinely used Rh phenotype lacking c and E |
DcE (R2R2) | iPSC | O | ∗D ∗cE No RHD ∗cE | + | 0 | + | + | 0 | 0 | + | 0 | 0 | Routinely used Rh phenotype lacking C and e |
ce (rr) | iPSC | O | No RHD ∗ce homozygous | 0 | 0 | + | 0 | + | + | + | 0 | 0 | Routinely used Rh phenotype lacking D, C, and E |
hrS− | iPSC∗ | O | ∗DAU0 ∗ceMO ∗DOL ∗ceBI | + | 0 | + | 0 | + | 0 | + | 0 | 0 | Uncommon; lacks high-prevalence antigen hrS Anti-hrS would be (0) nonreactive |
hrB− | iPSC∗ | O | ∗DIIIa-CE(4-7)-D ∗ceS homozygous | + | + | + | 0 | + | + | 0 | 0 | 0 | Uncommon; lacks high-prevalence antigen hrB Anti-hrB would be (0) nonreactive |
V+VS+ | iPSC∗ | O | ∗D ∗ce733G ∗DFV ∗ce733G | + | 0 | + | 0 | + | + | + | + | + | Uncommon; expresses low-prevalence antigens V and VS Anti-V/VS would be (+) reactive |
Rh null | iPSC | O | No RHD ∗ce (1kb del. KO) homozygous | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | Exceedingly rare; lacks RhD and RhCE proteins (0) nonreactive suggests antibody in the Rh system |
D-- | iPSC | O | RHD cDNA inserted at AAVS1 locus of Rh null iPSC | + | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | Exceedingly rare; expresses RhD and no RhCE (0) nonreactive suggests antibody to RhCE antigens |
Goa+ | iPSC | O | RHD∗DIVa cDNA inserted at AAVS1 locus of Rh null iPSC | + | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | Expresses low-prevalence antigen Goa, RhD, and no RhCE Anti-Goa would be (+) reactive |
DAK+ | iPSC | O | RHD∗DIIIa cDNA inserted at AAVS1 locus of Rh null iPSC | + | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | Expresses low-prevalence antigen DAK, RhD, and no RhCE Anti-DAK would be (+) reactive |
cDNA, complementary DNA; +, predicted positive for the antigen; 0, negative for the antigen.
Indicates iPSCs reprogrammed from rare donors.